Strides Pharma Science Q2 loss at Rs 149 crore

Total income, however, rose to Rs 1,035 crore in the second quarter as compared with Rs 920 crore in the year-ago period, Strides Pharma said in a regulatory filing.

Strides Pharma Science Q2 loss at Rs 149 crore
Strides Pharma had reported a net profit of Rs 19 crore for the year-ago period, image- company website

Strides Pharma Science on Monday reported a consolidated net loss of Rs 149 crore for the second quarter ended September 30, 2023.

The drug firm had reported a net profit of Rs 19 crore for the year-ago period.

Total income, however, rose to Rs 1,035 crore in the second quarter as compared with Rs 920 crore in the year-ago period, Strides Pharma said in a regulatory filing.

"The significant loss for the current quarter and half year ended September 30 has been on account of continuing operating losses, finance costs and others," the drug firm said.

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports, and auto, visit Zeebiz.com.

 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-mutual-fund-sip-retirement-corpus-planning-calculator-how-many-years-it-will-take-to-reach-inr-rs-30000000-with-4000-5000-and-6000-monthly-investment-market-linked-return-324325

Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000

https://www.zeebiz.com/personal-finance/news-sip-mutual-fund-power-of-compounding-retirement-corpus-planning-calculator-salary-inr-rs-25000-per-month-is-it-possible-to-create-over-26367030-fund-calculations-324366

Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations

https://www.zeebiz.com/personal-finance/news-reduce-home-loan-emi-or-reduce-tenure-rs-75-lakh-25-year-home-loan-which-option-can-save-rs-25-lakh-and-64-months-and-how-know-here-324393

Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here

https://www.zeebiz.com/personal-finance/photo-gallery-top-7-large-and-mid-cap-sip-mutual-funds-with-highest-best-xirr-returns-in-5-years-no-1-scheme-has-turned-rs-inr-15000-monthly-investment-into-rs-2054384-uti-icici-hdfc-bank-hsbc-quant-motilal-324344

Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others

https://www.zeebiz.com/markets/stocks/photo-gallery-stock-to-buy-for-long-term-on-new-year-samvat-2081-by-anil-singhvi-iifl-finance-share-price-target-nse-bse-smallcap-stock-324310

New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets

https://www.zeebiz.com/markets/stocks/photo-gallery-share-price-target-of-indian-oil-bharat-petroleum-hindustan-petroleum-largecap-psu-stocks-324329

PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-pnb-hdfc-bank-3-year-senior-citizen-fd-fixed-deposit-interest-rate-maturity-return-calculator-which-bank-gives-highest-on-inr-rs-500000-investment-state-bank-of-india-punjab-national-guaranteed-return-scheme-324094

Senior Citizen FD: SBI 3-year FD vs PNB 3-year FD vs HDFC Bank 3-year FD; which FD will give highest return on Rs 5 lakh investment

Written By: PTI
Updated: Mon, Oct 30, 2023
01:57 PM IST
Mumbai, PTI
RELATED NEWS
Strides Pharma Q1 Results: Net profit at Rs 84 crore vs net loss of Rs 29.5 crore a year ago Strides Pharma Q1 Results: Net profit at Rs 84 crore vs net loss of Rs 29.5 crore a year ago
Strides Pharma reports net profit of Rs 10.44 crore in Q4 Strides Pharma reports net profit of Rs 10.44 crore in Q4

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x